Search

Your search keyword '"Echinococcus multilocularis immunology"' showing total 145 results

Search Constraints

Start Over You searched for: Descriptor "Echinococcus multilocularis immunology" Remove constraint Descriptor: "Echinococcus multilocularis immunology"
145 results on '"Echinococcus multilocularis immunology"'

Search Results

1. High PD-1 and CTLA-4 expression correlates with host immune suppression in patients and a mouse model infected with Echinococcus multilocularis.

2. Design of a novel EmTSP-3 and EmTIP based multi-epitope vaccine against Echinococcus multilocularis infection.

3. Enhancing the therapeutic potential of P29 protein-targeted monoclonal antibodies in the management of alveolar echinococcosis through CDC-mediated mechanisms.

4. Echinococcus multilocularis serpin regulates macrophage polarization and reduces gut dysbiosis in colitis.

5. Targeting myeloid-derived suppressor cells promotes antiparasitic T-cell immunity and enhances the efficacy of PD-1 blockade (15 words).

6. Molecular characteristics of Echinococcus multilocularis FABP1 and its regulatory functions on murine macrophages.

7. Bioinformatic prediction and identification of immunogenic epitopes of the antigenic 14-3-3 protein of Echinococcus multilocularis.

8. Evaluation of fecal immunoassays for canine Echinococcus infection in China.

9. Dual Role of Hepatic Macrophages in the Establishment of the Echinococcus multilocularis Metacestode in Mice.

10. Digest the Sugar, Kill the Parasite: A New Experimental Concept in Treating Alveolar Echinococcosis.

11. Agranulocytosis leads to intestinal Echinococcus multilocularis oncosphere invasion and hepatic metacestode development in naturally resistant Wistar rats.

12. Immunohistological detection of small particles of Echinococcus multilocularis and Echinococcus granulosus in lymph nodes is associated with enlarged lymph nodes in alveolar and cystic echinococcosis.

13. Echinococcus multilocularis vesicular fluid induces the expression of immune checkpoint proteins in vitro.

14. Expansion of Host Regulatory T Cells by Secreted Products of the Tapeworm Echinococcus multilocularis .

15. Recent advances on innate immune pathways related to host-parasite cross-talk in cystic and alveolar echinococcosis.

16. Species specificity preliminary evaluation of an IL-4-based test for the differential diagnosis of human echinococcosis.

17. Immunotherapy of alveolar echinococcosis via PD-1/PD-L1 immune checkpoint blockade in mice.

18. Foxp3 + T Regulatory Cells as a Potential Target for Immunotherapy against Primary Infection with Echinococcus multilocularis Eggs.

19. Identification of emu-TegP11, an EF-hand domain-containing tegumental protein of Echinococcus multilocularis.

20. Larval Echinococcus multilocularis infection reduces dextran sulphate sodium-induced colitis in mice by attenuating T helper type 1/type 17-mediated immune reactions.

21. Environmental risk factors and changing spatial patterns of human seropositivity for Echinococcus spp. in Xiji County, Ningxia Hui Autonomous Region, China.

22. Immunological features and efficacy of the recombinant subunit vaccine LTB-EMY162 against Echinococcus multilocularis metacestode.

23. MicroRNA expression profile in RAW264·7 macrophage cells exposed to Echinococcus multilocularis metacestodes.

24. Depletion of FoxP3 + Tregs improves control of larval Echinococcus multilocularis infection by promoting co-stimulation and Th1/17 immunity.

25. Suppression of nemo-like kinase by miR-71 in Echinococcus multilocularis.

26. Dogs as victims of their own worms: Serodiagnosis of canine alveolar echinococcosis.

27. T-cell tolerance and exhaustion in the clearance of Echinococcus multilocularis: role of inoculum size in a quantitative hepatic experimental model.

28. Echinococcus multilocularis vesicular fluid inhibits activation and proliferation of natural killer cells.

29. Biochemical Characterization of Echinococcus multilocularis Antigen B3 Reveals Insight into Adaptation and Maintenance of Parasitic Homeostasis at the Host-Parasite Interface.

30. Laboratory Diagnosis of Echinococcus spp. in Human Patients and Infected Animals.

31. Immunology of Alveolar and Cystic Echinococcosis (AE and CE).

32. The timing of worm exclusion in dogs repeatedly infected with the cestode Echinococcus multilocularis.

33. Successful intestinal Echinococcus multilocularis oncosphere invasion and subsequent hepatic metacestode establishment in resistant RccHan™:WIST rats after pharmacological immunosuppression.

34. Immunoregulation in larval Echinococcus multilocularis infection.

35. Synthesis and Antigenicity against Human Sera of a Biotin-Labeled Oligosaccharide Portion of a Glycosphingolipid from the Parasite Echinococcus multilocularis.

36. Susceptibility versus resistance in alveolar echinococcosis (larval infection with Echinococcus multilocularis).

37. Clinical epidemiology of human AE in Europe.

38. An Echinococcus multilocularis Antigen B3 Proteoform That Shows Specific Antibody Responses to Active-Stage Alveolar Echinococcosis.

39. Evaluation of reactivity to Echinococcus spp. among rural inhabitants in Poland.

40. Prevention and Immunotherapy of Secondary Murine Alveolar Echinococcosis Employing Recombinant EmP29 Antigen.

41. Upregulation of PD-1 on CD4⁺CD25⁺ T cells is associated with immunosuppression in liver of mice infected with Echinococcus multilocularis.

42. Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice.

43. Investigating the impact of Echinococcus multilocularis vesicular fluid on human cells from healthy blood donors.

44. Diagnostics in cystic echinococcosis: serology versus ultrasonography.

45. [Evaluation of the diagnostic value of the ELISA tests developed by using EgHF, Em2 and EmII/3-10 antigens in the serological diagnosis of alveolar echinococcosis].

46. Th17 cells are associated with the Th1/Th2‑cell balance during Echinococcus multilocularis infection.

47. Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease.

48. Transcriptional profiles of cytokine/chemokine factors of immune cell-homing to the parasitic lesions: a comprehensive one-year course study in the liver of E. multilocularis-infected mice.

49. Time course of the antibody response in humans compared with rats experimentally infected with hepatic alveolar echinococcosis.

50. EmTIP, a T-Cell immunomodulatory protein secreted by the tapeworm Echinococcus multilocularis is important for early metacestode development.

Catalog

Books, media, physical & digital resources